Access recorded conference sections presented by local and international experts
Prof Mohit Khera
Description
Prof. Khera talks about the testosterone product labelling, which states that testosterone therapy is contraindicated in men with prostate cancer and warns about its use in men with BPH. The problem is that medical research does not support these concerns.
